SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 6/26/06 New River Pharmaceuticals Inc 8-K:8,9 6/26/06 2:1.1M Summit Fin’l Printing |
Document/Exhibit Description Pages Size 1: 8-K New River Pharmaceutical 8-K 6-26-2006 HTML 22K 2: EX-99.1 Miscellaneous Exhibit HTML 177K
New River Pharmaceutical 8-K 6-26-2006 |
NEW
RIVER PHARMACEUTICALS INC.
|
(Exact
name of Registrant as specified in
charter)
|
Virginia
|
54-1816479
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
file number)
|
(IRS
employer identification no.)
|
1881
Grove Avenue, Radford, Virginia
|
24141
|
(Address
of principal executive offices)
|
(Zip
code)
|
Registrant’s
telephone number, including area code
|
(540)
633-7978
|
Not
applicable
|
(Former
name or former address, if changed since last
report)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR
240.13e-4(c))
|
99.1
|
Presentation
made on June 26, 2006 by Dr. Donald Jasinski regarding clinical abuse
liability studies.
|
NEW
RIVER PHARMACEUTICALS INC.
|
||||
By:
|
/s/
Randal J. Kirk
|
|||
Randal
J. Kirk
|
||||
Chief
Executive Officer and President
|
Exhibit
Number
|
Exhibit
|
|
Presentation
made on June 26, 2006 by Dr. Donald Jasinski regarding clinical abuse
liability studies.
|
This ‘8-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on / For Period End: | 6/26/06 | None on these Dates | ||
12/6/05 | ||||
List all Filings |